Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses
Christopher J. Long1, Daniel J. Canter2, Marc C. Smaldone2, Tianyu Li3, Jay Simhan1, Boris Rozenfeld2, Ervin Teper2, David Y. T. Chen2, Richard E. Greenberg2, Rosalia Viterbo2, Robert G. Uzzo2, Alexander Kutikov2
Canadian Journal of Urology, Vol.19, No.5, pp. 6417-6422, 2012
Abstract Introduction: To characterize the relationship between tumor location and choice in selecting surgical cryoablation (SCA) versus percutaneous cryoablation (PCA) for treatment of renal masses.
Materials and methods: MEDLINE search was performed to identify studies in which cryoablation was used as therapy for renal masses. Tumor location was stratified as anterior, posterior, or lateral. Lesions were also described by endophycity (endo-, meso-, or exophytic) and polarity (upper, mid, or lower pole). Treating specialty was stratified as urology, radiology, or both. Comorbidity reporting rates were indexed for each manuscript.
Results: Thirty-seven manuscripts included 2344 lesions treated by SCA or PCA… More >